Pentose phosphate pathway inhibition metabolically reprograms CD8+ T cells and disrupts CNS autoimmunity.

Saved in:
Bibliographic Details
Title: Pentose phosphate pathway inhibition metabolically reprograms CD8+ T cells and disrupts CNS autoimmunity.
Authors: Grund EM; Mayo Graduate School.; Mayo Clinic Medical Scientist Training Program.; Translational Neuroimmunology Laboratory., Clarkson BD; Translational Neuroimmunology Laboratory.; Department of Laboratory Medicine and Pathology.; Center for Multiple Sclerosis and Autoimmune Neurology., Pucci S; Translational Neuroimmunology Laboratory.; Department of Neurology, and., Westphal MS; Translational Neuroimmunology Laboratory., Partida CM; Translational Neuroimmunology Laboratory.; Department of Neurology, and., Muhammad SA; Translational Neuroimmunology Laboratory.; Department of Neurology, and., Howe CL; Translational Neuroimmunology Laboratory.; Center for Multiple Sclerosis and Autoimmune Neurology.; Department of Neurology, and.; Division of Experimental Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Source: JCI insight [JCI Insight] 2025 Jun 10; Vol. 10 (14). Date of Electronic Publication: 2025 Jun 10 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: eCollection Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2379-3708
DOI:10.1172/jci.insight.184240